» Articles » PMID: 2999254

Maternal Antibody-mediated Protection Against Gastroenteritis Due to Rotavirus in Newborn Mice is Dependent on Both Serotype and Titer of Antibody

Overview
Journal J Infect Dis
Date 1985 Dec 1
PMID 2999254
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

In order to evaluate the role of passively acquired, rotavirus-specific antibodies in protection against diarrhea, we inoculated mouse dams with rotaviruses of various serotypes, and their newborns were orally challenged with a primate rotavirus (simian SA-11). Dams were immunized by using a regimen that included repeated inoculations administered either orally or intraperitoneally with adjuvant. The serum antibody response detected in dams by radioimmunoassay and plaque-reduction neutralization after parenteral immunization was approximately 15-fold and 80-fold greater, respectively, than that found after oral "hyperimmunization." Parenteral immunization with rotavirus serotypes either homotypic or heterotypic to the challenge virus protected suckling mice against diarrhea; protection was closely correlated with the in vitro neutralizing activity of maternal serum against the challenge virus. Oral immunization with only rotavirus strains homotypic to the challenge virus afforded protection; the lower immune response after oral immunization with rotaviruses heterotypic to the challenge virus resulted in a titer of neutralizing antibody to the challenge virus below the protective threshold. From our current studies it appears that antibody-mediated passive protection against rotavirus challenge is dependent on both serotype and titer of antibody.

Citing Articles

Transfer of Anti-Rotavirus Antibodies during Pregnancy and in Milk Following Maternal Vaccination with a Herpes Simplex Virus Type-1 Amplicon Vector.

Meier A, Suter M, Schraner E, Humbel B, Tobler K, Ackermann M Int J Mol Sci. 2017; 18(2).

PMID: 28212334 PMC: 5343965. DOI: 10.3390/ijms18020431.


Tandem truncated rotavirus VP8* subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenic.

Wen X, Cao D, Jones R, Hoshino Y, Yuan L Hum Vaccin Immunother. 2015; 11(10):2483-9.

PMID: 26091081 PMC: 4635725. DOI: 10.1080/21645515.2015.1054583.


Inclusion of a universal tetanus toxoid CD4(+) T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus ΔVP8* subunit parenteral vaccines.

Wen X, Wen K, Cao D, Li G, Jones R, Li J Vaccine. 2014; 32(35):4420-4427.

PMID: 24962749 PMC: 4104241. DOI: 10.1016/j.vaccine.2014.06.060.


Transmissible gastroenteritis virus (TGEV)-based vectors with engineered murine tropism express the rotavirus VP7 protein and immunize mice against rotavirus.

Ribes J, Ortego J, Ceriani J, Montava R, Enjuanes L, Buesa J Virology. 2010; 410(1):107-18.

PMID: 21094967 PMC: 7111951. DOI: 10.1016/j.virol.2010.10.036.


Passive immunity in Helicobacter-challenged neonatal mice conferred by immunized dams lasts until weaning.

Corthesy-Theulaz I, Corthesy B, Bachmann D, Velin D, Kraehenbuhl J Infect Immun. 2003; 71(4):2226-9.

PMID: 12654845 PMC: 152048. DOI: 10.1128/IAI.71.4.2226-2229.2003.